While discount cards can
assist patients in covering out-of-pocket expenses, their use by drug
manufacturers to steer users to more expensive drugs ultimately drives up costs
in the healthcare system. Many coupons and discount cards are targeted at
expensive brand name medications; while they allow the patient to afford their
established copay, the insurer is paying the balances of a significantly more
expensive drug than the generic or preferred brand – oftentimes, leading to
higher premiums the following years. Further, these discounts are usually
limited to a certain number of fills or restricted timeline and cannot be used by
patients in federal health plans.
Read Drug Discovery & Development's article on it here.
No comments:
Post a Comment